In the latest trading session, Teladoc (TDOC) closed at $9.45, marking a -0.84% move from the previous day. This change was narrower than the S&P 500's daily loss of 1.11%. Elsewhere, the Dow lost 0.77%, while the tech-heavy Nasdaq lost 1.49%.
The telehealth services provider's stock has dropped by 16.62% in the past month, falling short of the Medical sector's loss of 4.56% and the S&P 500's gain of 0.4%.
The investment community will be closely monitoring the performance of Teladoc in its forthcoming earnings report. In that report, analysts expect Teladoc to post earnings of -$0.20 per share. This would mark a year-over-year decline of 17.65%. Alongside, our most recent consensus estimate is anticipating revenue of $638.31 million, indicating a 3.36% downward movement from the same quarter last year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of -$5.80 per share and a revenue of $2.57 billion, signifying shifts of -332.84% and -1.36%, respectively, from the last year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Teladoc. These revisions help to show the ever-changing nature of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the company's business operations and its ability to generate profits.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. Right now, Teladoc possesses a Zacks Rank of #3 (Hold).
The Medical Services industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 79, finds itself in the top 32% echelons of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Teladoc Health, Inc. (TDOC) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
